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ABSTRACT We investigate the effect of mitochondrial localization and the Bcl-xL C-terminal transmembrane (TM) domain on
mitochondrial morphology and subcellular light scattering. CSM 14.1 cell lines stably expressed yellow ﬂuorescent protein
(YFP), YFP-Bcl-xL, YFP-Bcl-xL-DTM, containing the remainder of Bcl-xL after deletion of the last 21 amino acids corresponding
to the TM domain, or YFP-TM, consisting of YFP fused at its C-terminal to the last 21 amino acids of Bcl-xL. YFP-Bcl-xL and
YFP-TM localized to the mitochondria. Their expression decreased the intensity ratio of wide-to-narrow angle forward scatter by
subcellular organelles, and correlated with an increase in the proportion of mitochondria with an expanded matrix having greatly
reduced intracristal spaces as observed by electron microscopy. Cells expressing YFP-TM also exhibited signiﬁcant autophagy.
In contrast, YFP-Bcl-xL-DTM was diffusely distributed in the cells, and its expression did not alter light scattering or mito-
chondrial morphology compared with parental cells. Expression of YFP-Bcl-xL or YFP-Bcl-xL-DTM provided signiﬁcant re-
sistance to staurosporine-induced apoptosis. Surprisingly however, YFP-TM expression also conferred a moderate level of
cell death resistance in response to staurosporine. Taken together, our results suggest the existence of a secondary Bcl-xL
function that is mediated by the transmembrane domain, alters mitochondrial morphology, and is distinct from BH3 domain
sequestration.
INTRODUCTION
Proteins of the Bcl-2 family are important regulators of apo-
ptosis, a highly controlled form of cell death fundamental
to tissue development and homeostasis. Bcl-2 family mem-
bers share Bcl-2 homology (BH) domains. The family in-
cludes multidomain pro-apoptotic proteins (e.g., Bax, Bak)
containing BH1-BH3, multidomain anti-apoptotic proteins
(e.g., Bcl-2, Bcl-xL) containing all four BH1-BH4 domains,
and ‘‘BH3-only’’ pro-apoptotic proteins (e.g., Bid, Bad,
Bim, Noxa) containing only the BH3 domain. Multidomain
Bcl-2 family proteins also possess a transmembrane (TM)
C-terminal region, which can localize within organellar mem-
branes including the outer membrane of the mitochondria.
Bcl-2 family proteins can promote or inhibit apoptosis by
regulating the release of pro-apoptotic factors, such as cyto-
chrome c, Smac/Diablo, and Omi/Htra2, from the mitochon-
dria. Once released into the cytoplasm, these factors activate
caspases resulting in nuclear fragmentation and orderly
dismantling of the cell (1,2).
The mechanisms of action of Bcl-2 proteins are not com-
pletely elucidated. Interaction between Bcl-2 family mem-
bers is thought to involve the hydrophobic pocket formed by
the close arrangement of the BH1-BH3 domains of a multi-
domain protein. This hydrophobic pocket can ﬁt the exposed
BH3 domain of another multidomain protein or of a BH3-
only protein (3,4). In the case of Bax, the hydrophobic
pocket can also sequester the C-terminal domain within the
same monomer (5). Additionally, a possible interaction be-
tween the C-terminal of Bcl-xL and the hydrophobic pocket
of another Bcl-xL or Bax protein forming either homodimers
or heterodimers has been reported (6). Experimental evidence
strongly suggests that pro-apoptotic Bax and Bak, are nec-
essary formitochondria-mediated apoptosis, and that their sim-
ultaneous deletion renders cells highly resistant to many
apoptosis stimuli (7–9). Upon interaction with activated
BH3-only proteins, Bax and Bak are triggered to oligomerize
in the mitochondrial membrane forming pores, from which
pro-apoptotic factors, such as cytochrome c, are released
(10,11). Anti-apoptotic Bcl-2 family members can sequester
BH3 proteins that would otherwise activate Bax and Bak (9),
or they may directly interact with, and inhibit Bax or Bak
(12–15). Interaction of BH3-only proteins with Bcl-2 and
Bcl-xL can also serve to displace Bax/Bcl-2 or Bak/Bcl-xL
binding, and therefore reactivate Bax and Bak (15).
While some Bcl-2 family homologs are initially located
on the mitochondria (Bak, Bcl-2), others translocate from the
cytosol to the mitochondria in response to a cell death stim-
ulus (Bax, Bid) (1,2). Bcl-xL is usually initially associated
with mitochondria (16,17), but translocates in some cells
from the cytoplasm to the mitochondria after an apoptosis
stimulus (18,19). The localization of some Bcl-2 family pro-
teins to the mitochondria seems obviously necessary to
control directly the release of mitochondrial factors, such as
doi: 10.1529/biophysj.107.104323
Submitted January 17, 2007, and accepted for publication August 7, 2007.
Address reprint requests to N. N. Boustany, PhD, Tel.: 732-445-4500,
x6320; E-mail: nboustan@rci.rutgers.edu.
Editor: Michael Edidin.
 2008 by the Biophysical Society
0006-3495/08/01/286/12 $2.00
286 Biophysical Journal Volume 94 January 2008 286–297
cytochrome c. Consistent with this, Bcl-2 family members
can directly interact with the mitochondrion affecting both its
structure and function. Mitochondrial localization of pro-
apoptotic Bcl-2 family members has been associated with
alterations in mitochondrial morphology and bioenergetics
(20–25). At the same time, anti-apoptotic proteins, such as
Bcl-2 and Bcl-xL have been shown to preserve mitochondrial
integrity, including membrane potential, outer membrane
metabolite exchange, and osmotic integrity, in the face of
cell death insults (25–31).
The mechanisms by which structural changes in the
mitochondrial matrix and membranes may affect subsequent
function have long been under study. Electron microscopy
studies of mitochondria have shown that alterations in mito-
chondrial morphology are associated with different mito-
chondrial metabolic states (32–37). More recent electron
tomography studies of mitochondria strongly suggest that
speciﬁc compartmentation of the mitochondrial matrix may
help localize respiration, and in the case of apoptosis help to
free cytochrome c, and facilitate its release from the inter-
membrane space (20,38–41). As such, tracking changes in
mitochondrial structure can provide a way to monitor mito-
chondrial function, and may provide important clues regard-
ing the function of Bcl-2 family proteins in apoptosis at the
level of the mitochondria.
Changes in the morphology of the mitochondrial matrix
involve structural variation on the order of 10 to several
hundred nanometers, and are typically assessed by electron
microscopy (42). Electron microscopy is not easily amenable
to study dynamic changes in mitochondrial structure within
living cells or intact tissue. Thus, studies of isolated mito-
chondria (e.g., (34,37)), and of mitochondria within living
cells (e.g., (43–46)), or in whole tissues (e.g., (47,48)), have
relied on light scattering as a method to probe mitochondrial
morphology without sample ﬁxation or freezing. Light scat-
tering does not provide the level of morphological detail
achieved by electron microscopy. However, the technique
can be invaluable for continuous monitoring of nanoscale
morphological activity in situ, and ultimately discovering
time points at which structural changes occur and can be
further evaluated. Using this approach, we have found that
the light scattering properties of apoptotic rat undifferentiated
mesencephalic CSM 14.1 cells are altered after expression of
Bcl-xL fused to yellow ﬂuorescent protein (YFP-Bcl-xL)
(49). Utilizing the expression of a Bcl-xL mutant lacking the
C-terminal TM domain (YFP-Bcl-xL-DTM), we further show
in this study that the observed change in light scattering
requires mitochondrial localization, and is accompanied by
expansion of the mitochondrial matrix, as observed by
electron microscopy. In addition we also show that expres-
sion of the Bcl-xL C-terminal TM domain fused to YFP
(YFP-TM), and lacking the rest of the Bcl-xL protein, is by
itself sufﬁcient to alter mitochondrial morphology and con-
fer a limited level of resistance to staurosporine-induced
apoptosis.
METHODS
Gene constructs
Mouse BCL-xL was previously cloned into the pEYFP-C1 vector (Clontech,
BD Biosciences, Palo Alto, CA) using the BglII restriction site to yield a
plasmid encoding an enhanced yellow ﬂuorescent protein (YFP) fused to
Bcl-xL (49). YFP-BCL-xL-DTM, consisting of the YFP coding sequence
fused to BCL-xL, from which the last 63 bases were truncated, was generated
by polymerase chain reaction with BCL-xL as template and the upper primer,
59-GGACTCAGATCTATGTCTCAGAGCAACCGGGAG-39, and lower
primer 59-CTGCAGAATTCTCAGCGGTTGAAGCGTTCCTGGCC-39.
BCL-xL-DTM was subcloned into the pEYFP-C1 vector at the BglII/EcoRI
sites. The sequence of the ﬁnal product matched BCL-xL in the GenBank
database. Compared to the reference sequence, and in addition to the
C-terminal truncation, our sequence contained a C209G mutation, leading to
a glycine (GGC) instead of an alanine (GCG) at amino acid No. 70 in the
Bcl-xL protein. The same mutation was reported in one other BCL-xL Beta
sequence listed in the public database.
YFP-TM,consistingof theYFPcoding sequence fused to the last 63 bases of
the BCL-xL gene, was generated by polymerase chain reaction with pEYFP-C1
as template and theupper primer, 59-AGATCCGCTAGCGCTACCGGTCGC-
CACCATGGTGAGC-39 and lower primer 59-CGACTGCAGAATTCA-
TTTCCGACTGAAGAGTGAGCCCAGCAGAACCACGCCGGCCACA-
GTCATGCCCGTCAGGAACCAAGATCTGGATCC-39 (TM sequence
underlined). YFP-TM was subcloned into the pECFP-C1 vector (Clontech)
replacing the CFP sequence between theNheI and EcoR1 sites. The sequence
of the ﬁnal ampliﬁed and puriﬁed product after cloning into the pECFP-C1
vector conﬁrmed the presence of 59-YFP-TCCGGACTCAGATCT-TM-
TGA. The sequence betweenYFP and TM is the same as the beginning of the
multiple cloning site in the pEYFP-C1 vector.
Generation of stable cell-lines
Stable expression of YFP, and YFP-BCL-xL in inducible, rat mesencephalic
CSM14.1 cells was described previously (49). In this study, CSM 14.1 cells
were transfected at 80–90% conﬂuence with an empty plasmid encoding
hygromycin resistance (pIREShyg3, Clontech) and either YFP-BCL-xL-DTM
or YFP-TM (1:10 molar ratio, hygromycin plasmid: ﬂuorescent protein plas-
mid) using lipofectamine 2000 in OptiMEM medium (Invitrogen, Rockville
MD). Immortalized baby mouse kidney (iBMK) cells were transfected at
80–90% conﬂuence with YFP-BCL-xL, YFP-BCL-xL-DTM, YFP-TM, or
YFP. Twenty-four hours posttransfection, the cells were subcultured at 1000
cells/78.5 cm2 (10 cm dish) in growth medium supplemented with 400 mg/ml
hygromycin B (Invitrogen) for CSM14.1 selection, or 1 mg/ml geneticin sul-
fate (G418; Invitrogen) for iBMK selection. Isolated foci with yellow ﬂuo-
rescence were picked, serially diluted, and replated in 96-well plates to obtain
clonal cell-lines. In CSM14.1 cells, expression of YFP constructs was con-
ﬁrmed by immunoblots and ﬂuorescence microscopy; in iBMK cells, by ﬂuo-
rescence microscopy.
Cell culture
CSM 14.1 cell lines were maintained in Dulbecco’s modiﬁed Eagle’s me-
dium (DMEM) supplemented with 10% (V:V) fetal bovine serum (FBS),
1% (V:V, ;0.1 mM) nonessential amino acid, 100 Units/ml penicillin, 100
mg/ml streptomycin, and 1 mg/ml geneticin sulfate (G418). DMEM (catalog
No. 11965092), FBS, nonessential amino acids, penicillin, and streptomycin
were from Invitrogen. CSM 14.1 cells were kept undifferentiated in culture
at 32C in a 5% CO2 in air atmosphere. Stable CSM 14.1 cell-lines
transfected in this study with YFP-BCL-xL-DTM and YFP-TM were
maintained in the growth medium described above supplemented with 400
mg/ml hygromycin B. iBMK cells were maintained at 38C in a 5% CO2 in
air atmosphere in DMEM supplemented with 10% (V:V) FBS (Gemini Bio-
Products, West Sacramento, CA), and 100 Units/ml penicillin, 100 mg/ml
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streptomycin. For microscopy, cells were cultured on glass coverslips,
which, only in the case of CSM 14.1 cells, were coated with poly-D lysine
(MW . 300,000; Sigma Chemical, St. Louis, MO).
Immunoblots
CSM 14.1 cells were washed with phosphate buffered saline (PBS), and
lysed in SDS buffer (10 mM HEPES pH7.4, 38 mM NaCl, 2% sodium
dodecyl sulfate) supplemented with 1 mg/ml leupeptin, 1 mg/ml aprotinin,
and 0.2 mM phenylmethylsulfonyl ﬂuoride. Leupeptin, aptotinin, and phe-
nylmethylsulfonyl ﬂuoride were from Sigma Chemical. The lysates’ protein
content was determined by a colorimetric bicinchoninic acid analysis (BCA;
Pierce, Rockford, IL). For each cell variant, 30 mg of cell lysate protein were
resolved by 12% standard sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis. After transfer to a polyvinylidene diﬂuoride membrane by semidry
electroblotter (Bio-Rad, Hercules, CA), blots were blocked with 5% milk
with 0.05% Tween-20 in TBS buffer (20 mM Tris, 500 mM NaCl, pH 7.5),
incubated with mouse anti-GFP antibody (0.2 mg/ml, GFP-B-2, catalog No.
SC-9996; Santa Cruz Biotechnology, Santa Cruz, CA) followed by incuba-
tion with peroxidase conjugated goat anti-mouse IgG (0.2 mg/ml, Chemicon
International No. AP308P), and developed with enhanced chemilumines-
cence reagents (Amersham, Piscataway, NJ).
Fluorescence microscopy
YFP ﬂuorescence was imaged using a YFP ﬁlter cube (ﬁlter No. 46; Carl
Zeiss, Go¨ttingen, Germany): excitation, 500 6 20 nm bandpass; emission,
515 nm dichroic mirror followed by a 535 6 30 nm bandpass ﬁlter.
Mitochondria were also speciﬁcally imaged by immunoﬂuorescence of the
complex V unit. For this, cells were grown on glass coverslips to;70% con-
ﬂuence, washed with PBS, and ﬁxed for 1 min in a 1:1 V:V, methanol/
acetone solution, which had been stored at 20C. After three washes in
PBS, samples were incubated at 37C for 1 h in blocking buffer (2% fetal
bovine serum in PBS) followed by 1 h in blocking buffer supplemented with
2 mg/ml anti-OxPhos complex V subunit a-mouse IgG2b (A21350, Invitro-
gen). The samples were washed in PBS and further incubated at 37C for 1 h
in blocking buffer supplemented with 1.5 mg/ml Tetramethylrhodamine goat
anti-mouse IgG (T2762, Invitrogen). Coverslips were ﬁnally washed three
times with PBS and mounted on microscope slides with SlowFade (S2828;
Invitrogen). For the YFP CSM 14.1 cell variant, ﬁxation and immunoﬂu-
orescence labeling were done at room temperature, immediately after
imaging YFP ﬂuorescence. Rhodamine ﬂuorescence was detected with a
standard rhodamine ﬁlter cube (ﬁlter No. 20; Carl Zeiss): excitation, 546 6
12 nm bandpass; emission, 560 nm dichroic mirror followed by a 575–640
nm band pass ﬁlter. For the same image acquisition time in each channel,
the equivalent of 3.36% of rhodamine signal measured in the rhodamine
channel spilled over into the YFP channel, while the equivalent of 3.44% of
YFP signal measured in the YFP channel spilled over into the rhodamine
channel. Fluorescence images of samples double-labeled with YFP and anti-
Complex-V/rhodamine were corrected for this spillover.
Optical scatter microscopy
The optical scatter imaging technique was described previously in detail
(44,50). In this study, the specimensweremounted on the stage of an inverted
light microscope (Axiovert 200M; Carl Zeiss), with epiﬂuorescence and
differential interference contrast (DIC) capabilities. The condenser was
adjusted to central Ko¨hler illuminationwith a numerical aperture (NA) of 0.05
(condenser front aperture closed). A 10-nm bandpass interference ﬁlter
(Thorlabs, Newton, NJ) placed in the condenser housing yielded an incident
red beam centered at l¼ 630 nm. The images were collected with a 633 oil
immersion objective, NA ¼ 1.4, and displayed on a charge-coupled device
camera (Cascade 512B, Roper Scientiﬁc, Tucson, AZ). In a Fourier plane
conjugate to the back focal plane of the objective, a beam stop, diameter¼ 0.7
mm, was placed in the center of an iris with variable diameter. The beam stop
blocked the unscattered transmitted light through the sample, while the
variable iris diameter was switched between low NA and high NA positions,
collecting light scatteredwithin a solid angle bound by 3, u, 10 and 3,
u , 67, respectively.
Optical scatter image acquisition and analysis
Each coverslip with attached live cells was mounted by means of a steel plate
onto the stage of the inverted microscope. Just before mounting onto the
microscope’s stage, the DMEM growth medium was replaced with Leibo-
vitz L15 medium (Invitrogen) supplemented with 10% fetal bovine serum,
100 Units/ml penicillin, and 100 mg/ml streptomycin. The cells were moni-
tored by DIC, ﬂuorescence, and optical scatter microscopy at room temper-
ature and room air. For optical scatter imaging, two sequential dark-ﬁeld
images of each cell sample were acquired at high and low NA by manually
switching the diameter of the variable iris. A sample of L15 growth medium
was used to collect background scatter signal due to the microscope optics.
Dividing the background-subtracted high NA images by their corresponding
background subtracted low NA images resulted in ratiometric optical scatter
images, which directly encode the high-to-low NA optical scatter image
ratio (OSIR) at each pixel in the ﬁeld of view. The OSIR corresponds to
the intensity ratio of wide-to-narrow angle forward scatter deﬁned as
OSIR ¼
R 360
u¼0
R 67
u¼3 Fðu;uÞsinududuR 360
u¼0
R 10
u¼3 Fðu;uÞsinududu
; (1)
where F(u,u) gives the intensity of the light scattered in a given direction
deﬁned by the angles u and u. The value u is the angle between the scatter
direction and the direction of propagation of the incident light, and u is the
azimuthal angle of scatter.
Optical scatter images were acquired in IPlab (BD Biosciences Bio-
imaging, Rockville, MD) and processed in MatLab (The MathWorks,
Natick, MA). In each experiment, a segment was manually deﬁned around
every cell in the DIC images. These segments were overlaid onto the optical
scatter images such that data analysis was limited to regions containing a
cell. Only positively ﬂuorescent cells were analyzed in the transfected cell
variants. In addition, we further segmented the regions in the YFP-TM cells
that corresponded to bright and punctate ﬂuorescent mitochondria (see also
Results) to measure the OSIR at these speciﬁc locations. Two criteria were
used to locate these small bright regions in the YFP-TM ﬂuorescence
images. First, each of these regions was centered on a local maximum of the
intensity proﬁle. These local maxima were detected using a two-dimensional
order-statistic ﬁlter (51). Second, local maxima with intensity above back-
ground were selected. Since the YFP-TM ﬂuorescence images did not have
uniform exposure, setting a single threshold was not possible. Instead, a
Laplacian ﬁlter (52) was used to measure the second spatial derivative in the
image, and only retrieve peaks with large intensity changes. At completion
of the algorithm, we veriﬁed that the detected local peaks corresponded to
the punctate mitochondria in the ﬂuorescence images.
Cell death assay
Cell death resistancewas assayed bymeasuring the percentage of dead cells in
response to staurosporine (STS) treatment. Cells were cultured in 12-well
plates, and treated with 1 mM STS (Sigma Chemical) at 90% conﬂuence.
After 24 h, 40 mM propidium iodide (Invitrogen) was added to the incubated
cultures for 15 min. The cells were collected from the plates by pipetting and
trituration. Microscopic observation of the plates insured that all cells were
collected by this process. The cell suspension was concentrated to;53 105
cells/ml by centrifugation and partial removal of the supernatant. The number
of cells with positive propidium iodide ﬂuorescence in the ﬁnal cell sus-
pension was counted in a hemacytometer, and was taken to represent dead
cells, which had lost membrane integrity. Propidium iodide ﬂuorescence was
visualized with the rhodamine ﬁlter cube described above (ﬁlter No. 20,
Carl Zeiss).
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Electron microscopy and mitochondrial counting
CSM14.1 cells were grown to;90%conﬂuence in Sonic Seal Slidewells (No.
70365-42;ElectronMicroscopySciences,Hatﬁeld, PA).The cellswerewashed
(2 3 1 min) in PBS, and incubated for 2 h in Karnovsky’s modiﬁed ﬁxative
(2.5% glutaraldehyde, 4% paraformaldehyde, 0.1 M sodium cacodylate, 8
mM calcium chloride, pH ¼ 7.4; Electron Microscopy Sciences). After 2 h,
the ﬁxative was removed and replaced with another fresh aliquot of the same.
Directly after this ﬁxation, or after storage overnight at 4C, the cells were
washed (2 3 10 min) in cacodylate buffer (0.1 M sodium cacodylate, pH ¼
7.4), postﬁxed for 1 h at room temperature in cacodylate buffer supplemented
with 1% osmium tetroxide, dehydrated in a graded series of acetone, and
embedded in Epon-Spurr resin. Sections 90-nm-thin were cut on a model No.
EMUC6 ultramicrotome (LeicaMicrosystems, Bannockburn, IL). Sectioned
grids were stained with a saturated solution of uranyl acetate and lead citrate,
and observed at 80 kV on a JEOL 1200EX transmission electron microscope
(JEOL, West Chester, PA).
The electron micrographs revealed two types of mitochondria:
1. Mitochondria with a condensed matrix, which had visible cristae under
40,0003 magniﬁcation.
2. Mitochondria with an ‘‘expanded’’ matrix, in which the intracristal
spaces were greatly reduced and the cristae were not visible under up to
50,0003 magniﬁcation.
The two types of mitochondria were counted at 40,0003 in several
arbitrary ﬁelds. The number of ﬁelds, and therefore the total area spanned, in
each of the cell variants was the same. Approximately 150 mitochondria
were counted per sample, and the count generally spanned between 15 and
20 cells. Mitochondria with a matrix, which seemed partially expanded and
partially condensed, were taken as having a condensed matrix.
RESULTS
Expression of protein constructs in CSM 14.1 cells
To investigate the effect of Bcl-xL localization on mito-
chondrial morphology, we generated four stable CSM 14.1
cell lines expressing YFP, YFP-Bcl-xL, YFP-Bcl-DTM, or
YFP-TM (Fig. 1 A). YFP-Bcl-xL-DTM, consisted of YFP
fused to Bcl-xL lacking the last 21 amino acids at its
C-terminal; YFP-TM of YFP fused to the last 21 amino acids
Bcl-xL. These 21 amino acids, WFLTGMTVAGVVLLG-
SLFSRK, constitute the C-terminal hydrophobic TM domain
of Bcl-xL (16). YFP expression and subcellular localization
were conﬁrmed by immunoblots against YFP, and ﬂuores-
cence microscopy, respectively (Fig. 1, B and C). Cells ex-
pressing YFP-Bcl-xL and YFP-Bcl-xL-DTM exhibited a
band at ;50 kDa corresponding to expression of the fusion
construct YFP-Bcl-xL. Cells transfected only with YFP or
YFP-TM, and lacking Bcl-xL, exhibited a band between 29
and 37 kDa corresponding to YFP expression. Cells ex-
pressing YFP-Bcl-xL exhibited a ﬁlamentous yellow-green
ﬂuorescence distribution, which coincided with the distribu-
tion of the mitochondria assessed by immunoﬂuorescence
labeling of the ATP synthase (anti-OxPhos Complex V).
When the TM domain of Bcl-xL was deleted, the YFP-Bcl-
xL-DTM protein was diffusely distributed in the cells. In
contrast, YFP fused to the TM domain (YFP-TM) speciﬁ-
cally targeted the mitochondria. In .50% of the YFP-TM
cells, we also found very round and bright punctate mito-
chondria (arrows in last panel pair of Fig. 1 C). Using
ﬂuorescence images, which were corrected for spillover be-
tween the YFP and Complex V rhodamine ﬂuorescence
channels, we normalized the YFP signal per pixel to the
Complex V signal per pixel. Within a given cell, the nor-
malized YFP-TM signal in these bright punctate mitochon-
dria was typically approximately four times higher than the
normalized YFP-TM signal in their long and ﬁlamentous
counterparts.
Effect of Bcl-xL and Bcl-xL mutants on light
scattering by CSM 14.1 cells
Representative optical scatter images are shown alongside
DIC images for the CSM14.1 cell variants (Fig. 2 A). In the
optical scatter images, the pixels directly encode the local
value of the OSIR, which corresponds to the intensity ratio of
wide-to-narrow angle forward scatter (Eq. 1). Note that the
image pixel values correspond to OSIR 3 100. For spheres
with diameter between 0.015 mm and 2.72 mm, and with re-
fractive index ratio m ¼ 1.04, the calculated OSIR, based on
Mie theory, decreases nonlinearly and monotonically from
33.65 to 1.15 as a function of diameter (Fig. 2 B). The OSIR
was utilized as a measure of subcellular morphological
change caused by expression of Bcl-xL or its mutants. Cell
by cell analysis showed that the mean OSIR per cell was de-
creased from 2.22 for parental cells to 1.80 for YFP-Bcl-xL,
and 1.97 for YFP-TM cells. The difference between the
OSIR values of YFP-Bcl-xL and parental cells, and YFP-TM
and parental cells were signiﬁcant with p, 1014 by Student
t-test. In contrast, the mean OSIR per cell for Bcl-xL-DTMwas
2.23, and similar (p ¼ 0.78) to that of the parental cells (Fig. 2
C), while the mean OSIR value of the YFP cells, 2.44, was
10% higher than that of the untransfected cells (p , 103).
OSIR was binned into 326 elements with 0.1 intervals
spanning 1.15–33.65. Pixel histograms were normalized to
the number of pixels with OSIR ¼ 1.15, and are displayed in
the OSIR range 1.15–12.00, which included .95% of the
pixels (Fig. 3 A). The unnormalized histogram means, which
represent the ensemble of pixel values collected within a
given variant, largely corroborate the single cell analysis. In
particular, the mean pixel value was 18% lower for YFP-Bcl-
xL and 12% lower for YFP-TM compared with untransfected
parental cells. The mean pixel value of the Bcl-xL-DTM cells
was similar to that of the parental cells (Fig. 3 B). However,
the increase in the mean pixel value for YFP was only 1.3%
by this analysis.
The YFP-TM histogram had a larger relative contribution
from pixels with values above 200 compared with the YFP-
Bcl-xL histogram. To ﬁnd out whether this difference in the
YFP-TM histogram could be accounted for by the presence
of the bright and punctate mitochondria found by ﬂuores-
cence (Fig. 1 C), we speciﬁcally segmented out these bright
regions in the YFP-TM ﬂuorescence images and obtained a
pixel histogram of the OSIR values falling speciﬁcally on
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these image segments. This histogram (line with connected
small squares in Fig. 3 A) did not coincide with the YFP-TM
histogram, and the pixel values associated with the bright
and punctate mitochondria had an even larger proportion of
pixels with values .200. The segments associated with the
bright and round mitochondria represented only ;2% of all
the pixels analyzed in the YFP-TM case. Thus, their histo-
gram could not fully account for the shift in the YFP-TM
histogram above the YFP-Bcl-xL histogram.
Effect of Bcl-xL and Bcl-xL mutants on
mitochondrial morphology
Alterations in subcellular morphology underlie changes in
light scattering. Thus to corroborate the scattering data, and
better characterize the morphological changes at hand, we
used electron microscopy to image the cell variants. Since
our YFP constructs were designed based on their mitochon-
drial targeting properties, we speciﬁcally looked for altera-
tions in mitochondrial morphology. We identiﬁed two types
of mitochondria in the CSM 14.1 cell variants:
1. Mitochondria with a condensed matrix, in which the cristae
are clearly visible at 40,0003 (Fig. 4, black arrows).
2. Mitochondria with an ‘‘expanded’’ matrix, in which the
intracristal spaces were so reduced, the cristae could not be
discerned under 40,0003 or 50,0003 (Fig. 4, white arrows).
By counting the number of each type of mitochondria in
the cell variants considered, we found that cells expressing
FIGURE 1 YFP constructs, YFP expression, and YFP localization in CSM 14.1 cell lines. (A) Bcl-xL, Bcl-xL-DTM, which lacks the last 21 amino acids of
wild-type Bcl-xL, or TM, which consists of the last 21 amino acids of Bcl-xL, was fused to YFP. (B) YFP expression in CSM 14.1 cells was conﬁrmed by
Western blotting. As expected, a band between 29 and 37 kDa was found for cells transfected with YFP or YFP-TM. A band just above 50 kDa corresponds to
the presence of YFP-Bcl-xL and YFP-Bcl-xL-DTM (Bcl-xL is ;26 kDa). (C) Differential interference contrast (upper left panel) and ﬂuorescent images of
representative cells transfected with YFP, YFP-BCL-xL, YFP-BCL-xL-DTM, and YFP-TM. The distribution of YFP-Bcl-xL and YFP-TM (third and last panel
pairs) coincides with the distribution of mitochondria labeled with anti-OxPhos Complex V antibody. Very bright and punctate mitochondria were also found
in .50% of the YFP-TM transfected cells (arrows in last panel pair). YFP distribution is diffuse in cells transfected with YFP and YFP-BCL-xL-DTM.
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YFP-Bcl-xL or YFP-TM have a signiﬁcantly higher propor-
tion of mitochondria with expanded matrix (;70%), in con-
trast with untransfected cells (CSM), cells expressing YFP, or
cells expressing YFP-Bcl-xL-DTM, in which the proportion
of mitochondria with condensed matrix was signiﬁcantly
higher (Fig. 5).
In addition, we found that unlike all other variants, a large
number ofYFP-TMcells showed evidence of autophagy (Fig.
6). In particular, out of ;50 cells, 80% of the YFP-TM cells
hadmore than 20 autophagocytic vesicles, while,15%of the
cells had .20 autophagic vesicles in the other variants.
Moreover, all YFP-TM cells observed under electron mi-
croscopy had at least one such vesicle, while many cells in the
other variants had none.
Effect of Bcl-xL and Bcl-xL mutants on
apoptosis resistance
To study the potential relationship between mitochondrial
morphology alterations and apoptosis resistance, we tested
the effect of Bcl-xL and Bcl-xL mutants on cell death in
response to staurosporine. Both CSM 14.1 and iBMK cells,
which were tested in this part of the study, were previously
shown to undergo apoptosis in response to staurosporine
(49,53). After 24 h of treatment with 1 mM staurosporine, the
percentage of dead cells was 31.76 10.3% and 42.16 6.3%
for parental CSM 14.1 cells, and cells expressing YFP,
respectively (Fig. 7). As expected, CSM 14.1 cells over-
expressing Bcl-xL were resistant to cell death and had only
2.36 0.7% dead cells under the same treatment. YFP-Bcl-xL-
DTM induced as much cell death resistance as Bcl-xL, 7.26
5% dead cells. Surprisingly, in response to 24 h of STS
treatment, CSM 14.1 cells also exhibited a moderate level of
cell death resistance after YFP-TM transfection, 16.3% 6 5
dead cells, compared to 42.16 6.3 dead cells for YFP. To test
the reproducibility of these data in another cell line, we re-
peated our cell death resistance experiments in iBMK cells
stably transfected with the same YFP constructs. The iBMK
experiments corroborated theCSM14.1 results. In both cases,
Bcl-xL-DTM conferred a strong level of resistance similar to
FIGURE 2 Optical scatter images (OSI) and optical scatter image ratio (OSIR) values in the CSM 14.1 cell variants. (A) Differential interference contrast
(DIC, top panels), and OSI images of untransfected (CSM, leftmost panels) and transfected CSM 14.1 cells. OSI pixel values (color bar) encode local
measurements of OSIR, which can be theoretically described by Eq. 1. Note that the image pixels encode OSIR3 100. (B) Mie theory prediction of the average
OSIR per pixel expected from images of homogeneous suspensions of spheres with a given diameter. For spheres, the OSIR is expected to decrease
monotonically with increasing sphere diameterD, for 0.015mm,D, 2.75mm. (C) Mean OSIR per cell for each of the ﬁve CSM 14.1 cell variants. Error bars
represent the 95% conﬁdence interval of the mean, and the number in parenthesis is the number of cells tested.
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that of Bcl-xL, and YFP-TM provided a moderate level of
resistance.
DISCUSSION
Wehad previously observed that expression of YFP-Bcl-xL is
speciﬁcally localized on the mitochondria, and alters angular
light scattering by CSM 14.1 cells (49). By measuring the
intensity ratio of wide-to-narrow angle scatter, OSIR, we had
found a decrease in OSIR in response to YFP-Bcl-xL ex-
pression. In this study, we report that this optical scatter
change correlates with a high incidence of mitochondria with
an expanded matrix, in which the intracristal spaces were so
reduced they seemed absent as observed by electron micros-
copy at high magniﬁcation. Approximately 70% of mito-
chondria exhibited an expanded matrix in cells expressing
YFP-Bcl-xL, compared with only 30% of mitochondria with
an expanded matrix in parental cells, or cells expressing only
YFP. The relative OSIR values reported in this manuscript
reproduce our earlier data for untransfected, YFP and YFP-
Bcl-xL CSM14.1 cells (49). In both studies we found a;20%
OSIR decrease for YFP-Bcl-xL, and a ;5–10% OSIR in-
crease for YFP, compared with untransfected cells. The OSIR
increase in YFP cells could not account for the decrease in
OSIR observed in response to YFP-Bcl-xL nor was it
accompanied by alterations in mitochondrial morphology in
this study. Whether YFP alters other scatterers in the cyto-
plasm remains to be evaluated.
To investigate the role of the Bcl-xL TM domain and
mitochondrial localization in mediating the observed optical
scatter response and changes in mitochondrial morphology,
we used a YFP-Bcl-xL-DTM protein construct, in which
Bcl-xL lacks its last 21 amino acids corresponding to the
C-terminal TM domain. In contrast to YFP-Bcl-xL, expres-
sion of YFP-Bcl-xL-DTM was diffuse within the cells, did
not localize speciﬁcally on the mitochondria, did not alter
light scattering, and was not accompanied by an increase in
the percentage of mitochondria with an expanded matrix.
These results show that alterations in light scattering and
mitochondrial morphology that are induced by expression
of YFP-Bcl-xL, require the C-terminal TM domain and local-
ization of YFP-Bcl-xL on the mitochondria.
To ﬁnd out whether the BH domains of Bcl-xL are ne-
cessary to induce the observed mitochondrial alterations, we
synthesized a YFP-TM construct consisting of eYFP fused to
the last 21 amino acids of Bcl-xL, without the rest of the Bcl-
xL protein. As expected, this construct targeted the mito-
chondria. In addition, like YFP-Bcl-xL cells, cells expressing
YFP-TM had a lower OSIR value and a larger proportion
of mitochondria with an expanded matrix. Thus, the BH
FIGURE 4 Representative electron micrographs
of mitochondria with a condensed matrix (black
arrows) or an expanded matrix (white arrows) found
in the transfected CSM 14.1 cell variants. Mitochon-
dria with a condensed matrix were ones in which at
least one crista could be discerned, while mitochon-
dria with an expanded matrix had very reduced
intracristal spaces, such that no cristae could be
discerned under up to 50,0003 magniﬁcation.
FIGURE 3 Pixel analysis of OSI im-
ages. (A) Pixel histograms normalized to
the number of pixels with OSIR ¼ 1.15
for the untransfected CSM 14.1 cells
(black) and transfected CSM 14.1 vari-
ants (dark gray, YFP; light gray, YFP-
Bcl-xL; triangles, YFP-Bcl-xL-DTM;
circles, YFP-TM). Each histogram in-
cludes pixels from all the segmented cell
images considered within a given variant.
The line with connected small squares
corresponds to the pixel histogram of
the bright and punctate mitochondria,
which were found by ﬂuorescence in
YFP-TM cells (see also last panel pair
in Fig. 1 C) and segmented via a local
intensity peak detection algorithm. (B)
Mean of the unnormalized pixel histo-
grams for each of the CSM 14.1 cell
variants, and punctate mitochondria
found in the YFP-TM cells. The error
bar corresponds to the 95% conﬁdence
interval of the histogram mean.
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domains of Bcl-xL are not required, and the TM domain
is sufﬁcient to elicit changes in mitochondrial matrix
morphology. However, unlike Bcl-xL, a signiﬁcant portion
of the YFP-TM cells also exhibited a very large number of
vesicles, suggestive of excessive autophagy. At the same
time,.50% of the YFP-TM cells were found to contain very
bright and punctate mitochondria observed by ﬂuorescence
(Fig. 1 C, last panel pair) and with a larger proportion of
pixels with high OSIR values compared with the bulk of the
YFP-TM cells (Fig. 3). By normalizing the YFP ﬂuorescence
to that of anti-complex V ﬂuorescence, we found that the
ﬂuorescence intensity of the punctate mitochondria is greater
than the ﬂuorescence of ﬁlamentous looking mitochondria
within the same cell. It is therefore conceivable that
excessive YFP-TM expression on these punctate mitochon-
dria may have targeted them for autophagy. A direct
correlation between light and electron microscopy will be
required to conﬁrm whether the autophagocytic vesicles are
indeed the result of mitochondrial autophagy, and if they
correspond to the bright and punctate mitochondria observed
by ﬂuorescence. Kaufman et al. had reported that mitochon-
drial targeting requires two basic amino acids ﬂanking the
TM domain at each end (17). While in our construct, the TM
domain was not explicitly preceded by the x-domain of Bcl-
xL (17), it did include two basic amino acids at each end (Fig.
1 A): . . .K. . .R on the YFP end, where K is part of the YFP
terminus, and RK at the other end, coming from the original
C-terminal of Bcl-xL. This is consistent with the fact that
ﬂuorescence of our YFP-TM construct colocalized with anti-
complex V ﬂuorescence, and therefore was not simply a
result of subcellular YFP-TM aggregation without speciﬁc
localization to the mitochondria. The fact that YFP-TM, and
not YFP-Bcl-xL, should elicit an excessive autophagocytic
response, remains to be determined but could be related to
the interaction between Bcl-xL and the recently discovered
BH3 domain in Beclin1 (54,55). As such, YFP-TM, which
lacks the hydrophobic cleft of Bcl-xL, may be unable to bind
Beclin1 and maintain a baseline inhibition of autophagy.
Finally, to investigate the role of the TM domain in apo-
ptosis resistance, we measured the amount of cell death after
24 h of staurosporine treatment, which was previously
shown to induce apoptosis in CSM 14.1 and iBMK cells
(49,53). These results showed that in both CSM 14.1 and
iBMK cells, expression of YFP-Bcl-xL confers resistance to
cell death, thus corroborating the fact that staurosporine trig-
gers death via an apoptosis pathway. Moreover, expression
of YFP-Bcl-xL-DTM conferred similar cell death resistance
as expression of YFP-Bcl-xL. We also found, unexpectedly,
that expression of YFP-TM confers a moderate level of apo-
ptosis resistance (Fig. 7). Our data suggest that the presence
of the BH domains is sufﬁcient for apoptosis resistance and
does not require the TM domain or morphological alterations.
FIGURE 6 Lowmagniﬁcationelectronmicrographsshow-
ing a large number of autophagocytic vesicles (arrows) in a
representative YFP-TM cell, and comparison with a typical
YFP-Bcl-xL-expressing cell. (Inset) High magniﬁcation
view of a few autophagocytic vesicles in a YFP-TM cell.
FIGURE 5 Proportion of observed mitochondria with expanded or con-
densed matrix within each cell variant.
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This would be possible since, for example, the hydrophobic
pocket formed by the BH1-BH3 domains of Bcl-xL-DTM
could still sequester BH3-only proteins in the cytoplasm, and
in this way inhibit activation of Bax and Bak. Cytoplasmic
mutants of Bcl-xL may also still have minor associations with
subcellular membranes and have been reported to retain
effective anti-apoptotic activity (17). Certainly, in the case of
Bcl-2, a Bcl-2 cytoplasmic mutant lacking the transmem-
brane domain still possesses anti-apoptotic activity (56), and
the viral Bcl-2 homolog E1B19K, which targets organellar
membranes by myristoylation, lacks the C-terminal trans-
membrane domain and inhibits apoptosis by binding Bax or
Bak (57). Nevertheless, our results do not exclude the pos-
sible secondary role of the TM domain in apoptosis resis-
tance. In particular, the absence of the BH domains in the
YFP-TM construct did not fully obliterate the construct’s
ability to confer apoptosis resistance, and YFP-TM expres-
sion did alter mitochondrial morphology. While the mitigat-
ing role of autophagy in response to staurosporine-induced
cell death in the YFP-TM cells is not clear, the TM domain
of Bcl-xL could still contribute to apoptosis resistance by
mediating initial changes in mitochondrial morphology.
In this article, we have used light scattering and electron
microscopy to show that the TM domain of Bcl-xL mediates
changes inmitochondrial morphology. TheOSIR in our study
corresponds to the intensity ratio of wide-to-narrow angle
forward scatter, and gives a measure of scattering anisotropy
as an estimate of the angular deviation of the scattered light
from the forward direction. This ratio decreases monotoni-
cally as a function of diameter,D, as shown in Fig. 2 B. How-
ever, when particles are not spherical, the OSIR can be
sensitive to particle shape in addition to particle size, even
though it may not be able to distinguish between size and
shape alterations (44) .We had also previously shown that for
particle geometries approximating mitochondria, varying the
refractive index ratio, m, from 1.005 to 1.11 decreases the
OSIR by only 1.8% (44). If the refractive index of the
cytoplasm is taken as 1.36 corresponding to an equivalent
aqueous solution of protein with concentration 15% (15 g/100
ml) (58), changing m from 1.005 to 1.11 is equivalent to
changing the protein concentration of the mitochondria from
;20% to.90% (58). As such, changes in the refractive index
corresponding to extreme changes in particle composition
cannot fully account for the measured changes in OSIR for
particles the size of mitochondria. We therefore conclude that
changes in the OSIR are largely due to changes in particle
morphology, rather than composition. One way to interpret
the OSIR would be to state that the angular scattering
properties of the mitochondria represented by the OSIR are
equivalent to the OSIR properties of a sphere of a given size.
In this sense, the OSIR decrease measured in this study
corresponds to an increase in this ‘‘equivalent scattering
diameter.’’ However, the relationship between this equivalent
diameter and the ﬁne geometrical structure of the mitochon-
drial matrix is not clear. The expansion of the matrix and
reduction in intracristal spaces seen by electron microscopy
could correspond to an actual increase in matrix size, or could
represent matrix reconﬁguration without a signiﬁcant change
in matrix volume. A full three-dimensional characterization
of the change in matrix geometry, membrane contact sites,
and matrix volume will be necessary to further the electron
microscopy and scattering results presented in this study.
Changes in mitochondrial morphology can be produced by
several mechanisms, including control of matrix potassium,
calcium and ADP content, changes in the conﬁguration of the
adenine nucleotide translocase (ANT) and interaction with
dynamin-related proteins that normally control mitochondrial
fusion and ﬁssion. Bcl-2 family proteins have been shown to
inﬂuence some of these processes. Nonetheless, the transient
and steady-state modulation of mitochondrial morphology by
Bcl-2 family proteins has not been fully characterized. An
increase in mitochondrial volume effected by uptake of K1
into the matrix has been shown to stimulate respiration (59).
However, t-Bid was shown to facilitate cytochrome c release
by increasing mitochondrial K1 uptake, while Bcl-2 was
shown to inhibit K1 uptake and cytochrome c release, and
increase efﬂux of K1 from the matrix (31). At the same time,
overexpression of Bcl-2 correlated with an increase in
mitochondrial matrix volume, but no change in matrix K1
concentration, and may be related to a greater capacity for
calcium uptake into the matrix (60). ADP-induced phospho-
rylation leads to a change in mitochondrial morphology from
the ‘‘orthodox’’ to the ‘‘condensed’’ conﬁguration, in which
the matrix is shrunken with increased intracristal and inter-
membrane spaces but without an obvious reduction in total
mitochondrial volume (34). Conversely, binding of adenine
nucleotide to the ANT switches the ANT from its cytosolic to
matrix facing conformation and can result in a decrease in
intracristal spaces and inner membrane contraction without a
FIGURE 7 Percentage of dead CSM 14.1 and iBMK cells assessed by
propidium iodide exclusion after 24 h of treatment with 1 mM staurosporine.
Both cell types were stably transfected with YFP, YFP-BCL-xL, YFP-BCL-
xL-DTM, or YFP-TM. Mean 6 SD of at least three cell plates.
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change in matrix volume (61–65). The ANT may be able to
inﬂuence K1 inﬂux into the mitochondria (59,66). However,
changes in morphology involving the ANT may also be
mediatedby an alteration of inner/outermembrane contact sites
rich in ANT (e.g., ANT-VDAC contact sites) (65,67). In this
context, Bcl-xL was shown to facilitate ADP/ATP exchange
across the ANT in response to growth factor withdrawal (27).
Consistent with this, Bcl-2 was shown to increase ANT-
mediated ADP/ATP exchange, while Bax was shown to
decrease it (25). Bax dimers are also thought to facilitate
cytochrome c release by localizing and interfering with inner/
outermembrane contact points involving theANT (68). Lastly,
recent evidence points at the interaction of Bcl-2 family
proteins with dynamin-related proteins. Truncated-Bid can
disrupt Optic Atrophy 1 oligomers, which control cristae
junctions, and was shown to facilitate cytochrome c release
through a drastic inversion of inner membrane curvature and
remodeling of intracristal spaces independently of mitochon-
drial fusion (20,41). On the other hand, Bax promotes
mitochondrial fusion in healthy cells by interacting with
mitofusin-2 (22). This interaction may be inhibited during
apoptosis and contribute to unbalance Drp-1 induced mito-
chondrial fragmentation (22). Changes in morphology involv-
ing matrix expansion, as observed here, could, for example,
preconditionmitochondria to counteract death-promotingmor-
phological alterations induced by pro-apoptotic Bcl-2 mem-
bers, such as truncated-Bid and Bax/Bak. Alternatively, matrix
expansion could provide a means to control mitochondrial
metabolism and diffusion across mitochondrial membranes by
controlling intracristal space and contact points between the
inner and outer membranes.While the speciﬁc (anti-apoptotic)
functionofBcl-xL that requires localization to themitochondria
and alteration of matrix morphology even before a death
stimulus has not been elucidated in this study, our results
suggest that the requisite localization of wild-type Bcl-xL to
mitochondria may be necessary for a bioenergetic function
mediated by the TM domain and matrix morphology, and
distinct from and not requiring BH3 domain sequestration.
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